Therapeutic drug monitoring of methotrexate and its polyglutamated metabolites erythrocyte concentrations in rheumatoid arthritis

被引：0
|
作者：
Verdier, M. [1 ]
Rihouey, D. [1 ]
Bentue-Ferrer, D. [1 ]
Perdriger, A. [1 ]
Bellissant, E. [1 ]
机构：
[1] CHU Rennes, Serv Pharmacol, Rennes, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
360
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Methotrexate Polyglutamate Concentrations in Erythrocytes Are a Potential Tool for Therapeutic Drug Monitoring of Methotrexate Response in Rheumatoid Arthritis.
    De Rotte, C. F. J.
    den Boer, Ethan
    Bulatovic, Maja
    Pluijm, Saskia M. F.
    Hazes, Johanna M. W.
    De Jonge, Robert
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S914 - S914
  • [2] Therapeutic Drug Monitoring of Methotrexate: Assessment of Toxic Concentrations
    Aouinti, I.
    Salouage, I.
    Gaies, E.
    Charfi, R.
    Jebabli, N.
    Trabelsi, S.
    Lakhal, M.
    Klouz, A.
    [J]. DRUG SAFETY, 2013, 36 (09) : 884 - 884
  • [3] Erythrocyte methotrexate polyglutamate concentrations in patients with Crohn's Disease: towards a new therapeutic drug monitoring tool
    de Meeberg, M. Van
    Lin, M.
    Seinen, M.
    Fidder, H.
    Oldenburg, B.
    Bouma, G.
    de Jonge, R.
    Calasan, M. Bulatovic
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S339 - S339
  • [4] The methotrexate therapeutic response in rheumatoid arthritis
    Ortendahl, M
    Holmes, T
    Schettler, JD
    Fries, JF
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2084 - 2091
  • [5] STUDY OF METHOTREXATE METABOLITES CONCENTRATIONS IN RED BLOOD CELLS AND MONONUCLEAR CELLS IN RHEUMATOID ARTHRITIS
    Sygyrta, V.
    Gridneva, G.
    Lila, A.
    Samarkina, E.
    Baymeeva, N.
    Muraviev, Y.
    Aronova, E.
    Kudryavtseva, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 465 - 465
  • [6] The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?
    Stamp, Lisa
    Roberts, Rebecca
    Kennedy, Martin
    Barclay, Murray
    O'Donnell, John
    Chapman, Peter
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 678 - 687
  • [7] Determinants of Erythrocyte Methotrexate Polyglutamate Levels in Rheumatoid Arthritis
    den Boer, Ethan
    de Rotte, Maurits C. J. F.
    Pluijm, Saskia M. F.
    Heil, Sandra G.
    Hazes, Johanna M.
    de Jonge, Robert
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (11) : 2167 - 2178
  • [8] DETERMINANTS OF ERYTHROCYTE METHOTREXATE POLYGLUTAMATES LEVELS IN RHEUMATOID ARTHRITIS
    Den Boer, E.
    de Rotte, M.
    Pluijm, S.
    Hazes, M.
    de Jonge, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 542 - 542
  • [9] Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
    Medina, Frederic
    Plasencia, Chamaida
    Goupille, Philippe
    Ternant, David
    Balsa, Alejandro
    Mulleman, Denis
    [J]. THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 364 - 369
  • [10] Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
    I'Ami, Merel J.
    Marsman, Anneke F.
    Krieckaert, Charlotte L. M.
    Nurmohamed, Mike T.
    Ruwaard, Jill
    Visman, Ingrid M.
    Kneepkens, Eva L.
    Wolbink, Gertjan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345